David J Mazzo Insider Trading $EYPT EyePoint Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David J Mazzo.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David J Mazzo. David J Mazzo is Chief Executive Officer in Caladrius Biosciences, Inc. ($NBS) and Director in AVANIR PHARMACEUTICALS, INC. ($AVNR) and in EyePoint Pharmaceuticals, Inc. ($EYPT) and Director in pSivida Corp. ($PSDV) and Director in Neuralstem, Inc. ($CUR).
David J Mazzo in EyePoint Pharmaceuticals, Inc.
Trading Symbol: EYPTIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of David J Mazzo:
Holdings: 200,083 shares
Current Value: $332,138
Latest Transaction: Oct 11 2019
$EYPT Market Capitalization: $60.15M
$EYPT Previous Close: $1.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David J Mazzo in EyePoint Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVNR, NBS, EYPT, SNCA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 11 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 1.95 | 33,333 | 64,999 | 0 | ||
Oct 11 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 1.95 | 33,333 | 64,999 | 200,083 | 166.8 K to 200.1 K (+19.99 %) | |
Sep 10 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 0.00 | 417 | 0 | 0 | ||
Sep 10 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 0.00 | 417 | 0 | 166,750 | 166.3 K to 166.8 K (+0.25 %) | |
Jun 27 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | A | 2.65 | 40,000 | 106,000 | 40,000 | ||
Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 0.00 | 8,333 | 0 | 0 | ||
Jun 24 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 0.00 | 8,333 | 0 | 166,333 | 158 K to 166.3 K (+5.27 %) | |
Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Option Exercise | M | 1.77 | 20,000 | 35,400 | 0 | ||
Apr 01 2019 | EYPT | EyePoint Pharmaceu ... | Mazzo David J | Buy | M | 1.77 | 20,000 | 35,400 | 158,000 | 138 K to 158 K (+14.49 %) | |
Sep 10 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 0.00 | 417 | 0 | 417 | |
Sep 10 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 2.32 | 1,667 | 3,867 | 1,667 | |
Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | M | 0.00 | 17,500 | 0 | 0 | |
Jun 29 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Buy | M | 0.00 | 17,500 | 0 | 138,000 | 120.5 K to 138 K (+14.52 %) |
Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 0.00 | 8,333 | 0 | 8,333 | |
Jun 26 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | A | 1.95 | 33,333 | 64,999 | 33,333 | |
Apr 24 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Option Exercise | M | 1.13 | 120,000 | 135,600 | 0 | |
Apr 24 2018 | PSDV | EyePoint Pharmaceu ... | Mazzo David J | Director | Buy | M | 1.13 | 120,000 | 135,600 | 120,500 | 500 to 120.5 K (+24,000.00 %) |
Dec 19 2017 | PSDV | pSivida Corp. | Mazzo David J | Director | Option Exercise | A | 0.00 | 17,500 | 0 | 17,500 | |
Dec 19 2017 | PSDV | pSivida Corp. | Mazzo David J | Director | Option Exercise | A | 1.77 | 20,000 | 35,400 | 20,000 | |
Dec 14 2016 | PSDV | pSivida Corp. | Mazzo David J | Director | Option Exercise | A | 3.49 | 30,000 | 104,700 | 30,000 | |
Dec 04 2015 | PSDV | pSivida Corp. | Mazzo David J | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 |
Page: 1